Oved Amitay
Keine laufenden Positionen mehr
Karriereverlauf von Oved Amitay
Ehemalige bekannte Positionen von Oved Amitay
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
The Solve ME/CFS Initiative
The Solve ME/CFS Initiative Miscellaneous Commercial ServicesCommercial Services The Solve ME/CFS Initiative is a non-profit organization that focuses on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), long COVID, and other post-infection diseases. The non-profit company is based in Glendale, CA. The organization provides answers and links to information for those living with and managing ME/CFS or long COVID. ME/CFS is a chronic, complex, neuroimmune disease that limits the health and productivity of patients and is often triggered by an infection. The organization's advocacy cafe chat series features community members sharing their stories to advocate for change. The Solve ME Research Advisory Council includes professionals from many fields that touch on ME/CFS. The company was founded in 1987. Oved Amitay has been the CEO of the company since 2020. | Direktor/Vorstandsmitglied | 01.06.2020 | 16.10.2023 |
Vorstandsvorsitzender | 01.06.2020 | 16.10.2023 | |
Präsident | 01.06.2020 | 16.10.2023 | |
CENTOGENE N.V. | Corporate Officer/Principal | 01.11.2018 | 31.05.2020 |
Arrett Neuroscience, Inc. | Geschäftsführer | 01.01.2016 | 01.01.2018 |
Präsident | 01.01.2016 | 01.01.2018 | |
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 27.06.2012 | 01.06.2016 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.1998 | 01.01.2011 |
CeNeS Pharmaceuticals, Inc.
CeNeS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals, Inc. discovers and develops proprietary pharmaceuticals to prevent and treat disorders and injuries of the nervous system. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Peptor Ltd | Corporate Officer/Principal | - | - |
Ausbildung von Oved Amitay
Northeastern University | Graduate Degree |
The Hebrew University of Jerusalem | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Israel | 3 |
Deutschland | 2 |
Operativ
Corporate Officer/Principal | 5 |
President | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
CENTOGENE N.V. | Commercial Services |
Private Unternehmen | 5 |
---|---|
CeNeS Pharmaceuticals, Inc.
CeNeS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals, Inc. discovers and develops proprietary pharmaceuticals to prevent and treat disorders and injuries of the nervous system. The company is headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Peptor Ltd | Health Technology |
The Solve ME/CFS Initiative
The Solve ME/CFS Initiative Miscellaneous Commercial ServicesCommercial Services The Solve ME/CFS Initiative is a non-profit organization that focuses on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), long COVID, and other post-infection diseases. The non-profit company is based in Glendale, CA. The organization provides answers and links to information for those living with and managing ME/CFS or long COVID. ME/CFS is a chronic, complex, neuroimmune disease that limits the health and productivity of patients and is often triggered by an infection. The organization's advocacy cafe chat series features community members sharing their stories to advocate for change. The Solve ME Research Advisory Council includes professionals from many fields that touch on ME/CFS. The company was founded in 1987. Oved Amitay has been the CEO of the company since 2020. | Commercial Services |
Arrett Neuroscience, Inc. |
- Börse
- Insiders
- Oved Amitay
- Erfahrung